IL1B and Sepsis: Administration of IL-1β-preconditioned UC-MSCs led to decreased serum levels of IL-6, TNF-α, alanine aminotransferase and aspartate aminotransferase, and liver, lung, and kidney injury and increased bacterial clearance and survival in experimental CLP-induced sepsis (Song et al., 2017).